Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?
Related Research units
Abstract
Treatment intensification has improved outcomes for patients with head and neck cancer (HNC), but little has been reported on health-related quality of life (QoL) consequences. We investigated changes in QoL after (chemo)radiotherapy to identify patient characteristics that predict those whose QoL deteriorates most profoundly in the acute post-treatment period.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 9 |
| ISSN | 1368-8375 |
| Publication status | Published - 2012 |
| pubmed | 22502815 |
|---|
